[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Raghav Wadhwa [@raghavwadhwa](/creator/twitter/raghavwadhwa) on x 97.1K followers Created: 2025-07-17 09:09:31 UTC 🔷Competitive Landscape: Key Players and Pipeline Developments: 🔸Market Leaders and Innovators 🔹Novo Nordisk dominates the current Indian GLP-1 market, primarily through oral semaglutide (Rybelsus), which holds approximately XX% market share as of recent reports. XXXXX engagements  **Related Topics** [$novcde](/topic/$novcde) [Post Link](https://x.com/raghavwadhwa/status/1945772844417249655)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Raghav Wadhwa @raghavwadhwa on x 97.1K followers
Created: 2025-07-17 09:09:31 UTC
🔷Competitive Landscape: Key Players and Pipeline Developments:
🔸Market Leaders and Innovators 🔹Novo Nordisk dominates the current Indian GLP-1 market, primarily through oral semaglutide (Rybelsus), which holds approximately XX% market share as of recent reports.
XXXXX engagements
Related Topics $novcde
/post/tweet::1945772844417249655